Inactief instrument

Andere talen IM Cannabis Corp. Canadian Securities Exchange

Aandelen

IMCC

CA44969Q1090

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

IM Cannabis : MONTHLY PROGRESS REPORT Form 6 K	06/06
IM Cannabis Corp. announced that it has received CAD 2.091977 million in funding	29/05
IMC announces the termination of a preliminary term sheet with Kadimastem Ltd., a public company traded on the Tel Aviv Stock Exchange to fully focus on the recently legalized German market	28/05
IM Cannabis Corp. announced that it expects to receive CAD 2.091977 million in funding	26/05
IM Cannabis : Transcript	08/05
IM Cannabis : Financial Statements Q1 2024	08/05
IM Cannabis : Management's Discussion and Analysis Q1 2024	08/05
IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/05
IM Cannabis Corp. and Vessel Brand, Inc. Partner to Bring Vessel Cannabis Accessories to the Israeli Market	09/04
IM Cannabis, Avant Brands Sign BLK MKT's Licensing Deal for German Medical Cannabis Market	04/04
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	04/04
IM Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25/03
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25/03
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25/03
IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis	25/03
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K	06/03
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company	28/02
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company	28/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen IM Cannabis Corp. Canadian Securities Exchange

Aandelen

IMCC

CA44969Q1090

Andere talen

Filters